A common splice variant in HSD17B13 (rs72613567:TA) was recently found to be associated with a reduced risk of developing chronic liver disease in NAFLD patients and a reduced risk of progression to advanced fibrosis and cirrhosis. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.